Anthony Scott/Lancet Infect Dis

Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis.Garcia Quesada M Peterson ME Bennett JC Hayford K Zeger SL Yang Y Hetrich MK Feikin DR Cohen AL von Gottberg A van der Linden M van Sorge NM de Oliveira LH de Miguel S Yildirim I Vestrheim DF Verani JR Varon E Valentiner-Branth P Tzanakaki G Sinkovec Zorko N Setchanova LP Serhan F Scott KJ Scott JA Savulescu C Savrasova L Reyburn R Oishi K Nuorti JP Napoli D Mwenda JM Munoz-Almagro C Morfeldt E McMahon K McGeer A Mad'arova L Mackenzie GA Eugenia Leon M Ladhani SN Kristinsson KG Kozakova J Kleynhans J Klein NP Kellner JD Jayasinghe S Ho PL Hilty M Harker-Jones MA Hammitt LL Grgic-Vitek M Gilkison C Gierke R French N Diawara I Desmet S De Wals P Dalby T Dagan R Corcoran M Colzani E Chanto Chacon G Castilla J Camilli R Ang M Ampofo K Almeida SCG Alarcon P O'Brien KL Deloria Knoll M Pserenade Team
Lancet Infect Dis, (2025). 25:445-456

Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysis.Bennett JC Deloria Knoll M Kagucia EW Garcia Quesada M Zeger SL Hetrich MK Yang Y Herbert C Ogyu A Cohen AL Yildirim I Winje BA von Gottberg A Viriot D van der Linden M Valentiner-Branth P Suga S Steens A Skoczynska A Sinkovec Zorko N Scott JA Savulescu C Savrasova L Sanz JC Russell F Ricketson LJ Puentes R Nuorti JP Mereckiene J McMahon K McGeer A Mad'arova L Mackenzie GA MacDonald L Lepp T Ladhani SN Kristinsson KG Kozakova J Klein NP Jayasinghe S Ho PL Hilty M Heyderman RS Hasanuzzaman M Hammitt LL Guevara M Grgic-Vitek M Gierke R Georgakopoulou T Galloway Y Diawara I Desmet S De Wals P Dagan R Colzani E Cohen C Ciruela P Chuluunbat U Chan G Camilli R Bruce MG Brandileone MC Bigogo G Ampofo K O'Brien KL Feikin DR Hayford K Pserenade Team
Lancet Infect Dis, (2025). 25:457-470

Antibiotic resistance needs global solutions.Aiken AM Allegranzi B Scott JA Mehtar S Pittet D Grundmann H
Lancet Infect Dis, (2014). 14:550-1